ArticleEndocrine2013
A pathogenetic link between non-alcoholic fatty liver disease and celiac disease.
Article in Endocrine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 35 citations in OpenAlex.
- Prevalence and Risk Factors of Celiac Disease in Patients With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.JGH open : an open access journal of gastroenterology and hepatology · 2026Review
- Liver Involvement in Celiac Disease and Immune-Mediated Diseases of the Small Bowel.Liver international : official journal of the International Association for the Study of the Liver · 2025Review
- Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease.Nutrients · 2024Review
- Fatty liver disease that is neither metabolic nor alcoholic.Human pathology · 2023Article
- Fatty liver and celiac disease: Why worry?World journal of hepatology · 2023Review
- MAFLD and Celiac Disease in Children.International journal of molecular sciences · 2023Review
- Influence of genetically predicted autoimmune diseases on NAFLD.Frontiers in immunology · 2023Article
- A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver.Metabolites · 2022Article
- The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis.Clinical and experimental hepatology · 2021Article
- Celiac Disease and Elevated Liver Enzymes: A Review.Journal of clinical and translational hepatology · 2021Review
- Celiac Disease: Extraintestinal Manifestations and Associated Conditions.Journal of clinical gastroenterology · 2020Review
- The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study.Clinical and molecular hepatology · 2018Article
- Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications.Nutrients · 2018Review
- Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study.BMJ open gastroenterology · 2018Article
- To screen or not to screen? Celiac antibodies in liver diseases.World journal of gastroenterology · 2017Review
- Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease.Journal of hepatology · 2015Article
- Hepatic steatosis and steatohepatitis: Are they really two distinct entities?Current hepatology reports · 2014Article
- Review
- 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.The EPMA journal · 2014Review
- Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.World journal of gastroenterology · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-alcoholic fatty liver disease (NAFLD) has recently been recognized as the leading cause of the abnormalities in the liver function tests in the Western countries. Celiac disease (CD) is a permanent immunological intolerance to gluten proteins in genetically predisposed individuals. CD has been reported in 4-13 % of the cases with steatohepatitis, although the pathogenesis of the liver steatosis in CD patients is unclear. Based on the literature data, it can be concluded that the inclusion of serological markers of CD should be a part of the general workup in the patients with steatosis when other causes of the liver disease are excluded and in the patients with NAFLD when metabolic risk factors are not evident.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.